Drug Recall
Terminated
Historical recordClass II
PHENYLephrine 20 mg (PHENYLephrine HCL (USP) 20 mg, 5% Dextrose (USP) 250 mL) Volume: 252 mL. Single dose bag. For: Vidant Medical Center, By: Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-894-25
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
NORepiNEPHrine4mg (Norepinephrine Bitartrate (USP) 4 mg added to 0.9% Sodium Chloride (USP) 250 mL Volume: 254 mL Single dose bag. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-860-25
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
NORepiNEPHrine4mg (Norepinephrine Bitartrate (USP) 4 mg added to 5% Dextrose Inj. (USP) 250 mL (Concentration 16 mcg/mL) Volume: 254 mL Single dose bag. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-807-25
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
NORepiNEPHrine Bitartrate, USP 160 mcg in 5% Dextrose, USP QS 10mL. Volume 10mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-807-61
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
NORepiNEPHrine 16 (NORepiNEPHrine Bitartrate (USP) 16 mg, 5% Dextrose Inj. (USP) 250 mL. Volume: 266 mL. Single dose bag. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-834-25
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
Midazolam 1 mg/mL (Midazolam HCL (USP) 55 mg, 0.9% Sodium Chloride, (USP) QS 55 mL) Volume: 55mL. Single dose syringe. Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-401-76
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
Midazolam 0.5mg/mL (Midazolam HCL (USP) 50 mg, 0.9% Sodium Chloride, USP QS 100 mL) Volume: 100 mL. Single dose bag. For: Coral Gables Hospital, By: Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-408-10
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
Midazolam 1 mg/mL (Midazolam HCL USP 30 mg, 0.9% Sodium Chloride, USP QS 30 mL) Volume: 30 mL. Single dose syringe. For: Methodist Willowbrook Hospital, By: Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-401-63
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
MORphine 150 mg (Morphine Sulfate, USP 150mg in 0.9% Sodium Chloride, USP QS 30mL). Volume 30 mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-243-63
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
MORphine 1 mg/mL (Morphine Sulfate, USP 250mg, 0.9% Sodium Chloride, USP 250 mL). Volume 255 mL. Single dose bag. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-241-25
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
MAGnesium 2gm in NS 100 mL (MAGnesium SULfate (USP) 2 gm, 0.9% Sodium Chloride (USP) 100 mL). Volume: 104 mL. Single dose bag. For: Desert Regional Med Ctr By: Avella of Houston, 9256 Kirby Dr., Houston, TX 77054. NDC: 42852-907-10
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
MAGnesium 1gm in NS 100 mL (MAGnesium SULfate (USP) 1 gm, 0.9% Sodium Chloride (USP) 100 mL). Volume: 102 mL. Single dose bag. For: Salt Lake Regional Med Ctr By: Avella of Houston, 9256 Kirby Dr., Houston, TX 77054. NDC: 42852-906-10
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
HYDROmorphone 0.2mg/mL. (Hydromorphone HCL (USP) 20 mg, 0.9% Sodium Chloride (USP) QS 100 mL) Volume: 100mL. Single dose bag. Advanced Pharma, 9265 Kirby Dr., Houston,077054 TX. NDC 15082-221-10
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
HYDROmorphone 1 mg/mL (HYDROmorphone HCL (USP) 30 mg, 0.9% Sodium Chloride (USP) QS 30 mL) Volume: 30mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr., Houston, TX. NDC 42852-222-63
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
HEPARIN 1,000 Units in NS 250mL. (Heparin Sodium, USP 1,000 Units, 0.9% Sodium Chloride, USP 250 mL) Volume: 251 mL. Single dose bag. For: Adventist Medical Center Hanford. By: Avella of Huston, 9265 Kirby Dr., Houston TX, 77054. NDC 42852-747-25
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
HEPARIN 12,500 Units in 5% Dextrose. (Heparin Sodium, USP 12,500 Units, 5% Dextrose Inj., USP 250 mL) Volume: 252.5 mL. Single dose bag. Avella Specialty Pharmacy, 24416 N 19th Avenue Phoenix, AZ 85085. NDC 42852-745-25
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
fentaNYL 2 mcg/mL, 0.125% ROPivacaine, Fentanyl Citrate, USP 300 mcg, Ropivacaine HCL PF, USP 187.5 mg, 0.9% Sodium Chloride, USP QS 150 mL. Volume: 150 mL. Single dose cassette For: Methodist Dallas Medical Center. By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-278-86
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
fentaNYL 5 mcg Citrate, USP 5 mcg in 0.9% Sodium Chloride, USP QS 0.5mL. (10 mcg per mL) 5 mcg in 0.5 mL. Volume: 0.5 mL. Single dose syringe. For Cook Children's Med Ctr. By: Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-210-72
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
fentaNYL 3 mcg/mL, 0.1% Bupivacaine, Fentanyl Citrate, USP 750 mcg, Bupivacaine HCL PF, USP, 250 mg, 0.9% Sodium Chloride, USP QS 250 mL. Volume: 250mL. Single dose Cassette. For: Methodist St. John Hospital, By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-250-87
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass II
ePHEDrine Sulfate, USP 50mg in 0.9% Sodium Chloride USP QS 10mL. 50 mg/10 mL (5 mg/mL). Volume: 10 mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-891-61
by Avella of Deer Valley, Inc. Store 38
- Reason
- Lack of Assurance of Sterility: Potential leakage of bags.
- Recall initiated
- June 12, 2018
- Reported by FDA
- July 25, 2018
- Distribution
- Nationwide in the USA
View recall →
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer.